Loading…
Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis
A systematic review of the evidence was conducted to assess the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with Peyronie`s Disease (PD). A comprehensive search of the Cochrane Registry, PubMed and Embase databases was conducted to identify all controlled trial...
Saved in:
Published in: | BMC urology 2024-10, Vol.24 (1), p.217-10, Article 217 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c445t-1deea54407f0ab320e936403da0a006db283ca08ec51b21282ef0ebd68a065b33 |
container_end_page | 10 |
container_issue | 1 |
container_start_page | 217 |
container_title | BMC urology |
container_volume | 24 |
creator | Li, Guizhong Xu, Xiao Man, Libo |
description | A systematic review of the evidence was conducted to assess the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with Peyronie`s Disease (PD).
A comprehensive search of the Cochrane Registry, PubMed and Embase databases was conducted to identify all controlled trials, including randomised controlled trials (RCTs), cohort studies and case-control studies, focusing on the efficacy of LI-ESWT in treating PD, and published before February 2023. The size of plaques, curvature deviation, visual analog scale [VAS] and International Index of Erectile Function (IIEF) were the most commonly used tool to evaluate the treatment effectiveness of LI-ESWT.
There were 7 studies including 475 patients from 1999 to 2023. The meta-analysis of the data revealed that LI-ESWT could considerably enhance the proportion of men experiencing a reduction in penile plaques (RD 0.27, 95% CI: 0.04-0.50, P = 0.02), improvement in penile curvature (RD: 0.13; 95% CI, 0-0.26; p = 0.05), alleviation of pain (RD 0.22, 95% CI: 0.01-0.42, P = 0.04), and complete remission (RD 0.38, 95% CI 0.23-0.52, P |
doi_str_mv | 10.1186/s12894-024-01607-4 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c7322fc3dc674b14bfe1c214b4aa68e1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A811531092</galeid><doaj_id>oai_doaj_org_article_c7322fc3dc674b14bfe1c214b4aa68e1</doaj_id><sourcerecordid>A811531092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-1deea54407f0ab320e936403da0a006db283ca08ec51b21282ef0ebd68a065b33</originalsourceid><addsrcrecordid>eNptUstu1DAUjRCIlsIPsECW2LBJ61cShw2qKh6VRqILWFs39s2MhyQe7MwM-SP-gx_DM9OWToUsy9b1OUf3Hp8se83oOWOqvIiMq1rmlKfNSlrl8kl2ymTFci5r-vTB_SR7EeOSUlaponyenYhaVEXJqtOsn_lt7oYRh-jGieCvMYDxYeUDQkfiwpsfZAsbJOMCA6wm0vpAbnAKfnB_fkdiXUSI-J4AiVMcsYfRGRJw43BLYLCkxxFyGKCboosvs2ctdBFf3Z5n2fdPH79dfclnXz9fX13OciNlMebMIkIhJa1aCo3gFGtRSiosUKC0tA1XwgBVaArW8OQCx5ZiY0sFtCwaIc6y64Ou9bDUq-B6CJP24PS-4MNcQ0iNdqhNJThvjbCmrGTDZNMiMzydEqBUyJLWh4PWat30aA0OyaLuSPT4ZXALPfcbzZgsaqVUUnh3qxD8zzXGUfcuGuw6GNCvoxYJyYrU-Q769hF06dchubdHFUxQXol_qDmkCdzQ-t2v7UT1pUowwWjNE-r8P6i0LPbO-AFbl-pHBH4gmOBjDNjeD8mo3iVOHxKnU-L0PnFaJtKbh_bcU-4iJv4Cz0nSdQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3115130273</pqid></control><display><type>article</type><title>Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Li, Guizhong ; Xu, Xiao ; Man, Libo</creator><creatorcontrib>Li, Guizhong ; Xu, Xiao ; Man, Libo</creatorcontrib><description>A systematic review of the evidence was conducted to assess the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with Peyronie`s Disease (PD).
A comprehensive search of the Cochrane Registry, PubMed and Embase databases was conducted to identify all controlled trials, including randomised controlled trials (RCTs), cohort studies and case-control studies, focusing on the efficacy of LI-ESWT in treating PD, and published before February 2023. The size of plaques, curvature deviation, visual analog scale [VAS] and International Index of Erectile Function (IIEF) were the most commonly used tool to evaluate the treatment effectiveness of LI-ESWT.
There were 7 studies including 475 patients from 1999 to 2023. The meta-analysis of the data revealed that LI-ESWT could considerably enhance the proportion of men experiencing a reduction in penile plaques (RD 0.27, 95% CI: 0.04-0.50, P = 0.02), improvement in penile curvature (RD: 0.13; 95% CI, 0-0.26; p = 0.05), alleviation of pain (RD 0.22, 95% CI: 0.01-0.42, P = 0.04), and complete remission (RD 0.38, 95% CI 0.23-0.52, P < 0.00001). However, there were no significant differences in improvement of sexual function (MD: 1.44; 95% CI, -3.10-5.97; p = 0.53) between LI-ESWT and the placebo group.
According to these studies, LI-ESWT has the potential to decrease plaque size and improve penile curvature or pain in men with PD. The publication of robust evidence from additional well-designed long-term multicenter randomized controlled trials would provide more confidence regarding use of these devices in patients with PD.</description><identifier>ISSN: 1471-2490</identifier><identifier>EISSN: 1471-2490</identifier><identifier>DOI: 10.1186/s12894-024-01607-4</identifier><identifier>PMID: 39375617</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analysis ; Care and treatment ; Clinical trials ; Collaboration ; Controlled trial ; Erectile dysfunction ; Erection ; Extracorporeal Shockwave Therapy - methods ; Humans ; Lithotripsy ; Male ; Medical equipment ; Medical research ; Medicine, Experimental ; Meta-analysis ; Pain ; Patients ; Penile deviation ; Penile Induration - therapy ; Penis ; Peyronie’s disease ; Plaque ; Plaques ; Remission ; Remission (Medicine) ; Sexual disorders ; Shock waves ; Statistical analysis ; Treatment Outcome ; Visual perception</subject><ispartof>BMC urology, 2024-10, Vol.24 (1), p.217-10, Article 217</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c445t-1deea54407f0ab320e936403da0a006db283ca08ec51b21282ef0ebd68a065b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459888/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3115130273?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39375617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Guizhong</creatorcontrib><creatorcontrib>Xu, Xiao</creatorcontrib><creatorcontrib>Man, Libo</creatorcontrib><title>Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis</title><title>BMC urology</title><addtitle>BMC Urol</addtitle><description>A systematic review of the evidence was conducted to assess the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with Peyronie`s Disease (PD).
A comprehensive search of the Cochrane Registry, PubMed and Embase databases was conducted to identify all controlled trials, including randomised controlled trials (RCTs), cohort studies and case-control studies, focusing on the efficacy of LI-ESWT in treating PD, and published before February 2023. The size of plaques, curvature deviation, visual analog scale [VAS] and International Index of Erectile Function (IIEF) were the most commonly used tool to evaluate the treatment effectiveness of LI-ESWT.
There were 7 studies including 475 patients from 1999 to 2023. The meta-analysis of the data revealed that LI-ESWT could considerably enhance the proportion of men experiencing a reduction in penile plaques (RD 0.27, 95% CI: 0.04-0.50, P = 0.02), improvement in penile curvature (RD: 0.13; 95% CI, 0-0.26; p = 0.05), alleviation of pain (RD 0.22, 95% CI: 0.01-0.42, P = 0.04), and complete remission (RD 0.38, 95% CI 0.23-0.52, P < 0.00001). However, there were no significant differences in improvement of sexual function (MD: 1.44; 95% CI, -3.10-5.97; p = 0.53) between LI-ESWT and the placebo group.
According to these studies, LI-ESWT has the potential to decrease plaque size and improve penile curvature or pain in men with PD. The publication of robust evidence from additional well-designed long-term multicenter randomized controlled trials would provide more confidence regarding use of these devices in patients with PD.</description><subject>Analysis</subject><subject>Care and treatment</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Controlled trial</subject><subject>Erectile dysfunction</subject><subject>Erection</subject><subject>Extracorporeal Shockwave Therapy - methods</subject><subject>Humans</subject><subject>Lithotripsy</subject><subject>Male</subject><subject>Medical equipment</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Meta-analysis</subject><subject>Pain</subject><subject>Patients</subject><subject>Penile deviation</subject><subject>Penile Induration - therapy</subject><subject>Penis</subject><subject>Peyronie’s disease</subject><subject>Plaque</subject><subject>Plaques</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Sexual disorders</subject><subject>Shock waves</subject><subject>Statistical analysis</subject><subject>Treatment Outcome</subject><subject>Visual perception</subject><issn>1471-2490</issn><issn>1471-2490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUstu1DAUjRCIlsIPsECW2LBJ61cShw2qKh6VRqILWFs39s2MhyQe7MwM-SP-gx_DM9OWToUsy9b1OUf3Hp8se83oOWOqvIiMq1rmlKfNSlrl8kl2ymTFci5r-vTB_SR7EeOSUlaponyenYhaVEXJqtOsn_lt7oYRh-jGieCvMYDxYeUDQkfiwpsfZAsbJOMCA6wm0vpAbnAKfnB_fkdiXUSI-J4AiVMcsYfRGRJw43BLYLCkxxFyGKCboosvs2ctdBFf3Z5n2fdPH79dfclnXz9fX13OciNlMebMIkIhJa1aCo3gFGtRSiosUKC0tA1XwgBVaArW8OQCx5ZiY0sFtCwaIc6y64Ou9bDUq-B6CJP24PS-4MNcQ0iNdqhNJThvjbCmrGTDZNMiMzydEqBUyJLWh4PWat30aA0OyaLuSPT4ZXALPfcbzZgsaqVUUnh3qxD8zzXGUfcuGuw6GNCvoxYJyYrU-Q769hF06dchubdHFUxQXol_qDmkCdzQ-t2v7UT1pUowwWjNE-r8P6i0LPbO-AFbl-pHBH4gmOBjDNjeD8mo3iVOHxKnU-L0PnFaJtKbh_bcU-4iJv4Cz0nSdQ</recordid><startdate>20241008</startdate><enddate>20241008</enddate><creator>Li, Guizhong</creator><creator>Xu, Xiao</creator><creator>Man, Libo</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20241008</creationdate><title>Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis</title><author>Li, Guizhong ; Xu, Xiao ; Man, Libo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-1deea54407f0ab320e936403da0a006db283ca08ec51b21282ef0ebd68a065b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Care and treatment</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Controlled trial</topic><topic>Erectile dysfunction</topic><topic>Erection</topic><topic>Extracorporeal Shockwave Therapy - methods</topic><topic>Humans</topic><topic>Lithotripsy</topic><topic>Male</topic><topic>Medical equipment</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Meta-analysis</topic><topic>Pain</topic><topic>Patients</topic><topic>Penile deviation</topic><topic>Penile Induration - therapy</topic><topic>Penis</topic><topic>Peyronie’s disease</topic><topic>Plaque</topic><topic>Plaques</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Sexual disorders</topic><topic>Shock waves</topic><topic>Statistical analysis</topic><topic>Treatment Outcome</topic><topic>Visual perception</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Guizhong</creatorcontrib><creatorcontrib>Xu, Xiao</creatorcontrib><creatorcontrib>Man, Libo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ: Directory of Open Access Journals</collection><jtitle>BMC urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Guizhong</au><au>Xu, Xiao</au><au>Man, Libo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis</atitle><jtitle>BMC urology</jtitle><addtitle>BMC Urol</addtitle><date>2024-10-08</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>217</spage><epage>10</epage><pages>217-10</pages><artnum>217</artnum><issn>1471-2490</issn><eissn>1471-2490</eissn><abstract>A systematic review of the evidence was conducted to assess the efficacy of low-intensity extracorporeal shock wave therapy (LI-ESWT) for patients with Peyronie`s Disease (PD).
A comprehensive search of the Cochrane Registry, PubMed and Embase databases was conducted to identify all controlled trials, including randomised controlled trials (RCTs), cohort studies and case-control studies, focusing on the efficacy of LI-ESWT in treating PD, and published before February 2023. The size of plaques, curvature deviation, visual analog scale [VAS] and International Index of Erectile Function (IIEF) were the most commonly used tool to evaluate the treatment effectiveness of LI-ESWT.
There were 7 studies including 475 patients from 1999 to 2023. The meta-analysis of the data revealed that LI-ESWT could considerably enhance the proportion of men experiencing a reduction in penile plaques (RD 0.27, 95% CI: 0.04-0.50, P = 0.02), improvement in penile curvature (RD: 0.13; 95% CI, 0-0.26; p = 0.05), alleviation of pain (RD 0.22, 95% CI: 0.01-0.42, P = 0.04), and complete remission (RD 0.38, 95% CI 0.23-0.52, P < 0.00001). However, there were no significant differences in improvement of sexual function (MD: 1.44; 95% CI, -3.10-5.97; p = 0.53) between LI-ESWT and the placebo group.
According to these studies, LI-ESWT has the potential to decrease plaque size and improve penile curvature or pain in men with PD. The publication of robust evidence from additional well-designed long-term multicenter randomized controlled trials would provide more confidence regarding use of these devices in patients with PD.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39375617</pmid><doi>10.1186/s12894-024-01607-4</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2490 |
ispartof | BMC urology, 2024-10, Vol.24 (1), p.217-10, Article 217 |
issn | 1471-2490 1471-2490 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c7322fc3dc674b14bfe1c214b4aa68e1 |
source | Publicly Available Content Database; PubMed Central |
subjects | Analysis Care and treatment Clinical trials Collaboration Controlled trial Erectile dysfunction Erection Extracorporeal Shockwave Therapy - methods Humans Lithotripsy Male Medical equipment Medical research Medicine, Experimental Meta-analysis Pain Patients Penile deviation Penile Induration - therapy Penis Peyronie’s disease Plaque Plaques Remission Remission (Medicine) Sexual disorders Shock waves Statistical analysis Treatment Outcome Visual perception |
title | Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A20%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-intensity%20extracorporeal%20shock%20wave%20therapy%20for%20Peyroni%C3%A8s%20disease:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=BMC%20urology&rft.au=Li,%20Guizhong&rft.date=2024-10-08&rft.volume=24&rft.issue=1&rft.spage=217&rft.epage=10&rft.pages=217-10&rft.artnum=217&rft.issn=1471-2490&rft.eissn=1471-2490&rft_id=info:doi/10.1186/s12894-024-01607-4&rft_dat=%3Cgale_doaj_%3EA811531092%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-1deea54407f0ab320e936403da0a006db283ca08ec51b21282ef0ebd68a065b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3115130273&rft_id=info:pmid/39375617&rft_galeid=A811531092&rfr_iscdi=true |